Safety and Efficacy of SARS-COV-2-Specific T Cells as Adoptive Immunotherapy for High-Risk COVID-19 Patients: A Phase I/II, Randomized Clinical Trial
Cytotherapy(2022)
关键词
SARS-CoV-2, Virus-Specific T Cells, Adoptive Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要